Feds Say Pharma Cos. Can't Win Medicare Drug Price Suit
The federal government told a D.C. federal court that it shouldn't issue Merck & Co. Inc.'s summary judgment in its lawsuit challenging the Inflation Reduction Act's Medicare drug price negotiation program,...To view the full article, register now.
Already a subscriber? Click here to view full article